Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Financial Instrument [Axis] Marketable Securities [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Cash and Cash Equivalents [Axis] US Treasury Securities [Member] Money Market Funds [Member] Award Date [Axis] 2013 Through June 30, 2024 [Member] Legal Entity [Axis] Israeli Innovation Authority [Member] Business Acquisition [Axis] CardioSert Ltd [Member] Nitiloop [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Ministry of Economy [Member] Technion Research and Development Foundation Limited [Member] Finite-Lived Intangible Assets by Major Class [Axis] Technology [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Product and Service [Axis] Device [Member] Integrated Product [Member] Securities Purchase Agreement [Member] Litigation Settlement [Member] Alliance Investment Management, Ltd. [Member] Title and Position [Axis] Joseph Mona [Member] Chief Executive Officer [Member] Other Executives [Member] Sale of Stock [Axis] Series A Preferred Investment Options [Member] Series C Preferred Investment Options [Member] Series D Preferred Investment Options [Member] Existing Preferred Investment Options [Member] Inducement Investment Options [Member] Preferred Investment Option Exercise Inducement Offers Letter [Member] Private Placement [Member] Series F Preferred Investment Options [Member] Chief Executive Officer Executives and Employees [Member] Chief Executive Officer and Other Executives [Member] Chief Executive Officer Employees and Advisors [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Chief Financial Officer and Chief Technology Officer [Member] Cardio Sert [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Marketable securities Restricted cash Insurance recovery receivable related to legal settlement and legal expenses Prepaid expenses and other current assets Total current assets Property and equipment, net Operating right-of-use assets Total assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable Lease liabilities Legal settlement accrual Accrued liabilities Total current liabilities Non-current liabilities: Long-term lease liabilities Total liabilities Shareholders’ equity: Common stock; $0.01 par value; 60,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 15,965,633 and 11,707,317 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. Additional paid-in capital Accumulated deficit Total shareholders’ equity Total liabilities and shareholders’ equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Research and development, net General and administrative, net Operating loss Financing income, net Net loss Basic net loss per share Diluted net loss per share Basic weighted average common shares outstanding Diluted weighted average common shares outstanding Statement [Table] Statement [Line Items] Balances Balance, shares Share-based compensation Issuance of common stock upon exercise of warrants Issuance of common stock upon exercise of warrants, shares Net loss Issuance of common stock and warrants net of issuance costs Issuance of common stock and warrants net of issuance costs, shares Issuance of common stock relating to settlement agreement Issuance of common stock relating to settlement agreement, shares Balances Balance, shares Statement of Stockholders' Equity [Abstract] Net of issuance costs Net of issuance costs not paid Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to net cash flows used in operating activities: Depreciation of property and equipment Interest income and unrealized gains from marketable securities, net Share-based compensation Changes in assets and liabilities: Prepaid expenses and other assets Other payables and accrued liabilities Insurance recovery related to legal settlement and legal expenses received in cash Legal settlement paid in cash Net cash flows used in operating activities Investing activities: Purchases of property and equipment Purchases of marketable securities Proceeds from sales of marketable securities Proceeds from maturities of marketable securities Short term deposit Net cash flows provided by (used in) investing activities Financing activities: Issuance of common stock and warrants, net of issuance costs Net cash flows provided by financing activities Increase (decrease) in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Supplemental disclosure of cash flow information: Cash received from interest Supplemental disclosure of non-cash investing and financing activities: Right-of-use assets obtained in exchange for lease liabilities Issuance expenses Legal settlement settled through issuance of common stock Accrued bonus settled through grant of stock-option awards Deferred issuance expenses Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] GENERAL Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] SHARE CAPITAL Subsequent Events [Abstract] SUBSEQUENT EVENTS Use of estimates Fair value of financial instruments Share-based compensation Contingencies Recently issued accounting pronouncements SCHEDULE OF FINANCIAL ASSETS FAIR VALUE MEASUREMENT Date of incorporation Cash equivalents and marketable securities Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Assets, fair value Loss Contingencies [Table] Loss Contingencies [Line Items] Revenue grants received Grants receivable Additional grant receivable Repayment of government grants Net sales royalty percenatge Payment to acquire intangible assets Number of common shares issued for acquisition Number of common shares issued for acquisition, value Offering costs Gross proceeds from cash fee percentage Gross proceeds from management fee percentage Warrant issued, descriptions Stock issued during period, value, new issues Royalties percentage Purchase price of plaintiffs Litigation settlement amount Payment for litigation settlement Restricted common shares issued for legal settlement Settlement agreement liability Insurance recoverable Settlement amount recovery Legal expense Non operating loss on legal settlement Insurance recovery amount Number of share issued Litigation settlement Contigent bonus Contigent description Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Share price per share Existing investment options Agent fees and other offering expenses Gross proceeds Offering expenses Agggregate number of options granted Total expenses Stock option vested term Compensation percentage Annual bonus Subsequent Event [Table] Subsequent Event [Line Items] Aggregate offering price value Issuance of shares Gross proceeds from issuance of common stock Contingent bonus percentage Aggregate amount Interest income and unrealized gains from marketable securities net. Increase decrease in legal settlement and legal expenses received in cash. Increase decrease in legal settlement. Accrual Bonus settled through grant of stock option awards. Issuance expenses. Marketable Securities [Member] Israeli Innovation Authority [Member] Issuance of common stock value upon exercise of warrants. Additional grant receivable. Issuance of common stock shares upon exercise of warrants. Repayment of government grants. CardioSert Ltd [Member] Nitiloop [Member] Net sales royalty percentage. Ministry Of Economy [Member] Issuance of common stock value relating to settlement agreement. Technion Research And Development Foundation Limited [Member] Issuance of common stock shares relating to settlement agreement. Technology [Member] Offering costs. At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Gross proceeds from cash fee percentage. Gross proceeds from management fee percentage. Royalties percent. Device [Member] Integrated Product [Member] Payments of stock issuance costs not paid. Securities Purchase Agreement [Member] Litigation Settlement [Member] Settlement agreement liability. Insurance recoverable. Insurance recovery amount. Alliance Investment Management, Ltd. [Member] Joseph Mona [Member] Contigent bonus. Other Executives [Member] Series A Preferred Investment Options [Member] Series C Preferred Investment Options [Member] Series D Preferred Investment Options [Member] Existing Preferred Investment Options [Member] Inducement Investment Options [Member] Agent fees and other offering expenses. Preferred Investment Option Exercise Inducement Offers Letter [Member] Chief Executive Officer Executives and Employees [Member] Chief Executive Officer and Other Executives [Member] Chief Executive Officer Employees and Advisors [Member] Annual bonus Series F Preferred Investment Options [Member] Cardio Sert [Member] Contingent bonus percentage. Chief Financial Officer And Chief Technology Officer [Member] 2013 through June 30, 2024 [Member] Deferred issuance expenses. Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Research and Development Expense General and Administrative Expense Operating Income (Loss) Shares, Outstanding InterestIncomeAndUnrealizedGainsFromMarketableSecuritiesNet Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseInLegalSettlementAndLegalExpensesReceivedInCash Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Held-to-Maturity Securities Payments for (Proceeds from) Other Investing Activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Share-Based Payment Arrangement [Policy Text Block] Gain (Loss) from Litigation Settlement